12 citations
,
February 2020 in “The Journal of Clinical Endocrinology & Metabolism”
This study found that a self-assessed modified Ferriman-Gallwey score of 10 or higher indicates excess body hair, and suggests androstenedione measurement should accompany testosterone when evaluating hyperandrogenism.
39 citations
,
December 2001 in “JNCI: Journal of the National Cancer Institute”
This study found that enhanced expression of the Sonic hedgehog gene via an adenovirus vector accelerated hair regrowth in mice with chemotherapy-induced alopecia.
17 citations
,
June 2017 in “Journal of pharmaceutical sciences”
This study found that adapalene-loaded nanospheres in a hyaluronic acid gel enhanced skin penetration and were nonirritant, making them potentially suitable for treating acne on oily skin.
December 2021 in “International Journal of Research in Dermatology”
This study found that female pattern hair loss in Saudi women was associated with lower hematological parameters and serum ferritin levels, suggesting iron deficiency may contribute to the disease.
A user shared their experience withhair regrowth using supplements like NAC and DIM, and briefly using minoxidil with microneedling. They reported some improvement in hair density, but the community questioned the effectiveness compared to traditional treatments like finasteride.
Finasteride may be sufficient for diffuse thinning, but dutasteride is generally considered more effective, with a higher chance of hair growth. Adding oral minoxidil can improve results, though some users report side effects.
A person shared their positive experience with a hair transplant at Sule Hair Transplant in Istanbul, performed by Dr. Selahattin Tulunay using the Hybrid FUE technique with 5,000 grafts, costing €2,990. The user reported significant hair growth and satisfaction at 3, 6, and 12 months post-surgery, without using finasteride or minoxidil, but faced skepticism from others about the authenticity of their post.
A new hair loss treatment, PP405, showed promising Phase 2a results with 31% of patients experiencing over 20% hair density increase without systemic absorption, avoiding hormonal side effects. The treatment is expected to be expensive, with Phase 3 trials starting mid-2026, and there is skepticism about the data's strength.
The user has used minoxidil for five years and added microneedling for four weeks without seeing results. They are considering a hair transplant but are advised that hair loss will persist without a DHT blocker.